Evidence map›Paper›PMID 26330153›Full record

ArticleScientific reports2015

Rapid, high efficiency isolation of pancreatic ß-cells.

Susan M Clardy, James F Mohan, Claudio Vinegoni, Edmund J Keliher, Yoshiko Iwamoto, Christophe Benoist, Diane Mathis, Ralph Weissleder

Abstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Susan M ClardyCenter for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
James F MohanDivision of Immunology, Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts.
Claudio VinegoniCenter for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Edmund J KeliherCenter for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Yoshiko IwamotoCenter for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Christophe BenoistDivision of Immunology, Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts.
Diane MathisDivision of Immunology, Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts.
Ralph WeisslederCenter for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

Funding

Visualzing Lymphocyte Attack on Pancreas B CellsP01AI054904 · NIAID · JOSLIN DIABETES CENTER · PI MATHIS, DIANE J · 2003 to 2013
$16.0M
Training Grant in Molecular Imaging Research (MGH/HMS)T32CA079443 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI WEISSLEDER, MD, PHD, RALPH · 2000 to 2025
$10.1M
NCI NIH HHS T32 CA079443NCI NIH HHS T32CA79443NIAID NIH HHS P01 AI054904NIAID NIH HHS P01 AI54904
6 · The paper itself

Abstract

The ability to isolate pure pancreatic ß-cells would greatly aid multiple areas of diabetes research. We developed a fluorescent exendin-4-like neopeptide conjugate for the rapid purification and isolation of functional mouse pancreatic β-cells. By targeting the glucagon-like peptide-1 receptor with the fluorescent conjugate, β-cells could be quickly isolated by flow cytometry and were >99% insulin positive. These studies were confirmed by immunostaining, microscopy and gene expression profiling on isolated cells. Gene expression profiling studies of cytofluorometrically sorted β-cells from 4 and 12 week old NOD mice provided new insights into the genetic programs at play of different stages of type-1 diabetes development. The described isolation method should have broad applicability to the β-cell field.

Indexed as

AnimalsBoron CompoundsCell SeparationDiabetes Mellitus, ExperimentalExenatideFemaleGene Expression ProfilingGlucagonInsulinInsulin-Secreting CellsMice, Inbred C57BLMice, Inbred NODPeptidesSomatostatinVenomsBoron CompoundsExenatideGlucagonInsulinPeptidesSomatostatinVenoms

Identifiers

PMID26330153
PMCPMC4557033

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.